Health Dictionary Find a Doctor

Craniopharyngioma diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Marjan Khan M.B.B.S.[2]

Overview

Overview

The diagnostic evaluation of craniopharyngioma includes high-definition brain imaging. Brain MRI with and without contrast is the gold standard. Computed tomography (CT) scan is optional and may show some calcifications that can be seen in these tumors. However CT is not specific enough as a stand alone diagnostic test. Vascular imaging studies such as MR angiography (MRA) or CTA is decided on a case-by-case basis typically for surgical planning or if a possible vascular malformation is suspected.

Diagnostic Study of Choice

Diagnostic Study of Choice

Study of choice

References

References

  1. Müller HL, Merchant TE, Puget S, Martinez-Barbera JP (May 2017). “New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma”. Nat Rev Endocrinol. 13 (5): 299–312. doi:10.1038/nrendo.2016.217. PMID 28155902.
  2. Cohen LE (August 2016). “Update on childhood craniopharyngiomas”. Curr Opin Endocrinol Diabetes Obes. 23 (4): 339–44. doi:10.1097/MED.0000000000000264. PMID 27258775.
  3. Martinez-Gutierrez JC, D’Andrea MR, Cahill DP, Santagata S, Barker FG, Brastianos PK (December 2016). “Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy”. Neurosurg Focus. 41 (6): E2. doi:10.3171/2016.9.FOCUS16325. PMID 27903124.
  4. Patel VS, Thamboo A, Quon J, Nayak JV, Hwang PH, Edwards M, Patel ZM (December 2017). “Outcomes After Endoscopic Endonasal Resection of Craniopharyngiomas in the Pediatric Population”. World Neurosurg. 108: 6–14. doi:10.1016/j.wneu.2017.08.058. PMID 28838874.
  5. Müller HL (June 2014). “Craniopharyngioma”. Endocr. Rev. 35 (3): 513–43. doi:10.1210/er.2013-1115. PMID 24467716.

Template:WH Template:WS

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH